Placebo response in phase 2 and 3 trials of systemic and biological therapies for atopic dermatitis—A systematic review and meta-analysis
Journal of the European Academy of Dermatology and Venereology | Feb 14, 2020
Efficacy of tildrakizumab by patient demographic and disease characteristics across a phase 2b and 2 phase 3 trials in patients with moderate-to-severe chronic plaque psoriasis
Journal of the European Academy of Dermatology and Venereology | Feb 14, 2020
Consumption of polyphenols in coffee and green tea alleviates skin photoaging in healthy Japanese women
Clinical, Cosmetic and Investigational Dermatology | Feb 14, 2020
Results of the guideline-based treatment for pemphigus: A single-centre experience with 84 cases
Journal of the European Academy of Dermatology and Venereology | Feb 13, 2020
Increased mortality in patients with porphyria cutanea tarda—A nationwide cohort study
Journal of the American Academy of Dermatology | Feb 11, 2020